Late initiation of combination antiretroviral therapy in Canada: a call for a national public health strategy to improve engagement in HIV care

Autor:	Curtis Cooper, Anita Rachlis, Julio S. G. Montaner, Ann N. Burchell, Erin Ding, Marina B. Klein, Nima Machouf, Angela Cescon, Sean B. Rourke, Keith Chan, Alexis K. Palmer, Janet Raboud, Colin Davey, Christos M. Tsoukas, Mona Loutfy, Sophie Patterson, Robert S. Hogg
Jazyk:	angličtina
Rok vydání:	2015
Předmět:	Gerontology Adult Male medicine.medical_specialty Canada Time Factors Anti-HIV Agents antiretroviral therapy Human immunodeficiency virus (HIV) Short Report late initiation HIV Infections Logistic regression medicine.disease_cause 03 medical and health sciences 0302 clinical medicine Acquired immunodeficiency syndrome (AIDS) Medicine Humans 030212 general & internal medicine Late initiation 0303 health sciences 030306 microbiology business.industry Public health public health Public Health Environmental and Occupational Health HIV Middle Aged medicine.disease 3. Good health CD4 Lymphocyte Count AIDS Infectious Diseases Cohort Observational study Residence Female HIV care business Demography
Zdroj:	Journal of the International AIDS Society
ISSN:	1758-2652
Popis:	Introduction : Combination antiretroviral therapy (ART) significantly decreases morbidity, mortality and HIV transmission. We aimed to characterize the timing of ART initiation based on CD4 cell count from 2000 to 2012 and identify factors associated with late initiation of treatment. Methods : Participants from the Canadian Observational Cohort (CANOC), a multi-site cohort of HIV-positive adults initiating ART naively after 1 January 2000, in three Canadian provinces (British Columbia, Ontario and Quebec) were included. Late initiation was defined as a CD4 count
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7034da8ddad01f52f40d23e8b1071c17 http://europepmc.org/articles/PMC4595457 Zobrazit plný text záznamu Plný text ve formátu PDF